MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-GJ-25-0005559
Sidmak Laboratories (India) Private Limited - pharma in Valsad, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2026
₹86.22 Cr
▲ 1% YoY
Net profit · FY 2026
₹13.16 Cr
Net margin 15.3%
EBITDA · FY 2026
₹17.82 Cr
EBITDA margin 20.7%
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹5 Cr
Issued & subscribed
Open charges
₹5 Cr
Satisfied ₹8.52 Cr
Company age
43 yrs
Est. 1983
Employees · EPFO
402
Provident fund records
About Sidmak Laboratories (India) Private Limited
Data last updated:
Sidmak Laboratories (India) Private Limited is a private limited company based in Valsad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 May 1983 and has been in existence for over 43 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ1983PTC006157. Its GSTIN is 24AADCS9914R1ZN (Gujarat). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹5 Cr. It was formerly known as Sidmak Laboratories (India) Limited. It is led by directors including Udaykumar Ratilal Shah (Whole-Time Director) and Ashok Indulal Bhuta.
Its last annual general meeting (AGM) was held on 10 July 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at S. No. 4662 4663 And 4779 & 4785 N. H. No. 48 Abrama P. B. No. 121, Valsad, Gujarat, India – 396001.
As per the financials filed for FY 2026, the company reported a revenue of ₹86.22 Cr, a growth of 1% compared to the previous year. For the same year it recorded a net profit of ₹13.16 Cr (net margin 15.3%) and EBITDA of ₹17.82 Cr (EBITDA margin 20.7%). Revenue has declined at a compounded annual rate (CAGR) of 6% over three years and 3% over five years.
The company has about 402 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Sidmak. As per MCA filings, the company has open charges of ₹5 Cr and satisfied charges of ₹8.52 Cr on record. Court records list 37 cases involving the company, including 7 filed by the company and 30 filed against it; 7 cases are pending. The company has 7 deals on record (6 secondary share transfers, 1 funding round), with disclosed funding of ₹4.45 Cr; the latest was in March 2024. The company has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 3 overdue payments to 2 micro and small suppliers.
Sidmak Laboratories (India) Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-25-0005559). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sidmak.com.
Company details
CIN U24230GJ1983PTC006157
Registration Number 006157
Incorporation Date 06 May 1983
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 10 July 2026
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-GJ-25-0005559
Key People
Udaykumar Ratilal Shah Whole-Time Director Ashok Indulal Bhuta Director Vinayak Tulsidas Bhalani Director Recognitions & Rankings of Sidmak Laboratories (India)
Contact details
Sidmak Laboratories (India) Private Limited's registered office is in Valsad, Gujarat. Its website is sidmak.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressS. No. 4662 4663 And 4779 & 4785 N. H. No. 48 Abrama P. B. No. 121, Valsad, Gujarat, India – 396001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sidmak Laboratories (India) Private Limited, buy the company report.
Comprehensive company report
Sidmak Laboratories (India) Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Sidmak Laboratories (India) operates one associated brand: Sidmak. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops and manufactures pharmaceutical compositions | sidmak.com |
Business activity
The main business activity of Sidmak Laboratories (India) is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Sidmak Laboratories (India) Private Limited, buy the company report.
Financials of Sidmak Laboratories (India) Private Limited
FY 2026 filings availableSidmak Laboratories (India) Private Limited reported revenue of ₹86.22 Cr (up 1% YoY) for FY 2026.
Revenue · FY 2026
₹86.22 Cr ▲ 1%
Net profit · FY 2026
₹13.16 Cr margin 15.3%
EBITDA · FY 2026
₹17.82 Cr margin 20.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 1%
3 years · compounded
▲ 6%
5 years · compounded
▼ 3%
EBITDA CAGR growth
1 year
▲ 34%
3 years · compounded
▲ 126%
5 years · compounded
▲ 3%
Revenue rose 1% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 3%. EBITDA rose 34% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹86.22 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹17.82 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹13.16 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 20.7% | ||||
| Net Profit Margin | 15.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sidmak Laboratories (India) Private Limited, buy the company report.
Board of directors of Sidmak Laboratories (India) Private Limited
Sidmak Laboratories (India) has 6 current directors and 13 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashok Indulal Bhuta Also directs: KNK Trading Private Limited, Sanghvi Properties Pvt Ltd, Aditya Infotech Private Limited and 5 more | Director | 18 Dec 2025 | 0 Years 10 Months | Current |
| Vinayak Tulsidas Bhalani Also directs: Bioquest Innovations LLP | Director | 26 Sep 1996 | 30 Years 1 Months | Current |
| Udaykumar Ratilal Shah Also directs: Pack-Well Industries (Valsad) Pvt Ltd | Whole-Time Director | 01 Aug 2014 | 12 Years 3 Months | Current |
| Swati Chetan Jagetia Also directs: Unimed Investments Limited, Solar Power Technologies India LLP, Rayo Enterprises LLP and 5 more | Director | 28 May 2025 | 1 Years 5 Months | Current |
| Raj Jaysingh Kariya Also directs: Sanghvi Properties Pvt Ltd, Asawari Property Private Limited, Cannon Realty Private Limited and 5 more | Director | 12 Apr 2024 | 2 Years 6 Months | Current |
| Rajiv Chhelshankar Pandya Also directs: Unimed Investments Limited | Director | 12 Apr 2024 | 2 Years 6 Months | Current |
Auditor
Sidmak Laboratories (India) Private Limited is audited by VALIA & TIMBADIA for the financial year 2026.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VALIA & TIMBADIA | FY 2026 | 112241W |
Shareholding
The shareholding of Sidmak Laboratories (India) Private Limited is on record for 5 financial years, the latest being FY 2026, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sidmak Laboratories (India) Private Limited, buy the company report.
Charges & borrowings
Open charges
₹5 Cr
Satisfied charges
₹8.52 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 Jan 2012 | 10333458 | Axis Bank Limited | ₹50 Lakh | Open | |
| 07 Jan 2004 | 80011661 | Axis Bank Limited | ₹4.5 Cr | Open | |
| 08 Feb 2012 | 10336133 | Axis Bank Limited | ₹85 Lakh | Satisfied | |
| 15 Nov 1997 | 90100569 | State Bank of India | ₹7.55 Cr | Satisfied | |
| 10 Nov 1984 | 90097147 | Bank of Baroda | ₹12 Lakh | Satisfied |
To see the full charge records of Sidmak Laboratories (India) Private Limited, buy the company report.
Total charge records: 5 View all charges
Deals & funding
Sidmak Laboratories (India) Private Limited has 7 deals on record (6 secondary share transfers, 1 funding round), with disclosed funding of ₹4.45 Cr; the latest was in March 2024.
Total deals
7
Secondary share transfers
6
Funding round
1
Disclosed funding
₹4.45 Cr
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2024 | Secondary share transfer | Undisclosed | Buyer: Mockinon Enterprises Private Limited Seller: M J Pharmaceuticals Limited |
| Dec 2018 | Secondary share transfer | Undisclosed | Buyer: Shanghvi Finance Private Limited Seller: Sholapur Organics Private Limited , Nirmit Exports Private Limited , Jeevanrekha Investrade Private Limited |
| Aug 2017 | Secondary share transfer | Undisclosed | Buyer: Sun Petro Private Limited , Flamboyawer Finance Private Limited Seller: Sanghvi Finance Private Limited, Package Investrade Private Limited |
| Apr 2010 | Funding round | ₹4.45 Cr | Investors: Nirmit Exports Private Limited |
| Apr 2010 | Secondary share transfer | Undisclosed | Buyer: M J Pharmaceuticals Limited, Sholapur Organics Private Limited , Sanghvi Finance Private Limited Seller: Ranbaxy Drugs & Chemicals Company, 3 individuals |
To see the full deal history of Sidmak Laboratories (India) Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Sidmak Laboratories (India) Private Limited has 37 court cases on record: 7 filed by Sidmak Laboratories (India), 30 filed against it. 7 cases are pending and 30 are disposed.
Total cases
37
Filed by the company
7
Filed against the company
30
Pending
7
Disposed
30
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 20 | 19 | 0 |
| High courts | 10 | 4 | 3 |
| NCLAT | 7 | 7 | 4 |
Cases on record (5 of 37)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLAT, NCLAT New Delhi | Court case (Caveat) | Filed against the company by an individual | Pending |
| NCLAT, NCLAT New Delhi | Company appeal | Filed against the company by individuals | Pending |
| NCLAT, NCLAT New Delhi | Interim or miscellaneous application | Filed against the company by an individual | Pending |
| High Court, UTTARAKHAND | Court case (WPMS) | Filed by the company against State of Uttarakhand and 2 others | Pending |
| High Court, GUJARAT | Special civil application | Filed by the company against Union of India and 1 other | Pending |
To see the full case history of Sidmak Laboratories (India) Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Sidmak Laboratories (India) Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 3 overdue payments to 2 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (2 of 2)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Rich Prints Private Limited | |||
| an individual supplier |
To see the full MSME payment records of Sidmak Laboratories (India) Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Sidmak Laboratories (India) Private Limited has a workforce of 402 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
Employee count
402
Active EPFO establishments
1
Employee growth
2.55%
GST
Sidmak Laboratories (India) has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AADCS9914R1ZN | Gujarat | Active | 01 Jul 2017 |
| 05AADCS9914R1ZN | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sidmak Laboratories (India) Private Limited, buy the company report.
Recent activity
Sidmak Laboratories (India) Private Limited has 19 board changes on record since 1996: 6 appointments and 13 cessations. The latest: Ashok Indulal Bhuta was appointed as Director on 18 Dec 2025.
AGM
Sidmak Laboratories (India) Private Limited last Annual general meeting of members was held on 10 Jul 2026 as per latest MCA records.
Filing
Sidmak Laboratories (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Ahmedabad.
Appointed
Ashok Indulal Bhuta was appointed as Director.
Appointed
Swati Chetan Jagetia was appointed as Director.
Ceased
Krishnaprasad Menon ceased to be Additional Director.
Ceased
Vivek Mittal ceased to be Additional Director.
Appointed
Raj Jaysingh Kariya was appointed as Director.
Appointed
Rajiv Chhelshankar Pandya was appointed as Director.
Charges
A charge with Axis Bank Limited of Rs. 4.50 Cr registered on 07 Jan 2004 with Charge ID 80011661 was modified on 02 Nov 2022.
Ceased
Dwarko Topandas Khilnani ceased to be Director.
Ceased
Padmanabh Ramchandra Barpande ceased to be Director.
Ceased
Shivkumar Dhalumal Israni ceased to be Director.
20 earlier events are in the company report.
Frequently asked questions
Sidmak Laboratories (India) is an active private limited company based in Valsad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 06 May 1983 (43+ years old) and is registered under CIN U24230GJ1983PTC006157.
Sidmak Laboratories (India) has 6 current directors:
- Udaykumar Ratilal Shah - Whole-Time Director
- Ashok Indulal Bhuta - Director
- Vinayak Tulsidas Bhalani - Director
- Swati Chetan Jagetia - Director
- Raj Jaysingh Kariya - Director
- Rajiv Chhelshankar Pandya - Director
The latest financial statements of Sidmak Laboratories (India) on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 10 July 2026. Year-wise statements from 2015 are in the company report.
The GSTIN of Sidmak Laboratories (India) is 24AADCS9914R1ZN, registered in Gujarat. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 05AADCS9914R1ZN (Uttarakhand).
The CIN (Corporate Identification Number) of Sidmak Laboratories (India) is U24230GJ1983PTC006157. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sidmak Laboratories (India) has 37 court cases on record: 7 filed by the company and 30 filed against it. 7 are pending. Most are in the district courts.
Sidmak Laboratories (India) was incorporated on 06 May 1983, making it 43+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Sidmak Laboratories (India) has 7 deals on record (6 secondary share transfers, 1 funding round), with disclosed funding of ₹4.45 Cr; the latest was in March 2024.
Ashok Indulal Bhuta was appointed as Director on 18 Dec 2025. Swati Chetan Jagetia was appointed as Director on 28 May 2025. Krishnaprasad Menon ceased to be Additional Director on 17 Jul 2024. Sidmak Laboratories (India) has 19 board changes on record in total.
Yes, Sidmak Laboratories (India) is registered as a medium enterprise under Udyam registration (number: UDYAM-GJ-25-0005559).
Sidmak Laboratories (India) has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 3 overdue payments to 2 micro and small suppliers. The latest return was filed on 08 May 2019.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages